Lipril

Lisinopril, the active ingredient in Lipril, is an angiotensin‑converting enzyme (ACE) inhibitor presented as an oral tablet of unspecified strength for oral administration. It is used to manage high blood pressure and to improve outcomes in patients with heart failure, post‑myocardial infarction, and diabetic nephropathy, primarily in adult populations.

GNH USA supplies Lipril as a licensed, Good Distribution Practice‑compliant pharmaceutical product, providing reliable access to hospitals, pharmacies and clinics worldwide through its established international supply network and dedicated regulatory support.

Lipril (lisinopril) is an ACE inhibitor that acts on the renin‑angiotensin system to control blood pressure and related cardiovascular conditions. - Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. - Heart failure: improves symptoms, decreases hospitalizations, and enhances survival. - Post‑myocardial infarction: reduces the likelihood of subsequent cardiac events. - Diabetic nephropathy: slows the progression of kidney damage in diabetic patients.

Lisinopril may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Cough: persistent dry cough. - Dizziness: light‑headedness, especially on standing. - Headache: mild to moderate intensity. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of the face, lips, tongue or airway. - Severe hypotension: marked drop in blood pressure. - Acute kidney injury: sudden decrease in renal function.

Before initiating Lipril, several safety considerations should be observed. - Renal function monitoring: assess serum creatinine and eGFR regularly. - Electrolyte monitoring: watch for hyperkalemia, especially with potassium‑sparing agents. - History of angioedema: avoid use in patients with prior angioedema episodes. - Pregnancy: use only if clearly needed after risk‑benefit evaluation. - Elderly patients: start at lower doses and titrate cautiously. - Store at room temperature: keep in the original container, protect from moisture.

Lisinopril can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Aliskiren: combined renin‑angiotensin blockade increases risk of renal impairment. - Lithium: ACE inhibition may raise lithium levels, leading to toxicity. - NSAIDs: concurrent use can reduce renal perfusion and impair kidney function.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect; monitor blood pressure. - Potassium supplements or potassium‑sparing diuretics: increase risk of hyperkalemia. - Other antihypertensives: additive blood‑pressure‑lowering effect may require dose adjustments.